In this issue:
Amisulpride, aripiprazole, and olanzapine in patients with schizophrenia-spectrum disorders
Psychosis relapse during treatment with LIAs in patients with schizophreniaspectrum disorders
Antipsychotic medication vs psychological intervention vs a combination of both in adolescents with FEP
Association of end point definition and trial duration in RCTs of schizophrenia medications
Bipolar disorder and cross-generational familial association with schizophrenia and major depression
Impairment of magnetoencephalographically measured high-frequency oscillations in visual cortex during emerging psychosis
Multiple adverse childhood experiences with schizophrenia is associated with more severe symptomatology
Meta-analysis of UA levels in schizophrenia
Neurocognitive functioning during symptomatic states and remission in BAD and schizophrenia
Real world experiences of treating schizophrenia with cariprazine
Comparative efficacy and tolerability of 32 oral antipsychotics for the acute treatment of multi-episode schizophrenia
Please login below to download this issue (PDF)